Pelvic inflammatory disease in adolescents

Adolescent Medicine Clinics

Volumn 15, Issue 2, 2004, Pages 273-285

  Banikarim, Chantay ^a   Chacko, Mariam R ^b,c  

^a ST JOSEPH'S HOSPITAL AND MEDICAL CENTER   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c Texas Children's Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFOTETAN; CEFOXITIN; CEFTRIAXONE; CEPHALOSPORIN; CLINDAMYCIN; DOXYCYCLINE; GENTAMICIN; LEVOFLOXACIN; METRONIDAZOLE; OFLOXACIN;

ADOLESCENT; CLINICAL FEATURE; CONTRACEPTION; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; DRUG COST; ECTOPIC TISSUE; HOSPITALIZATION; HUMAN; INFECTION RISK; LABORATORY TEST; MENSTRUAL CYCLE; MENSTRUAL IRREGULARITY; MENSTRUATION DISORDER; PELVIC INFLAMMATORY DISEASE; PERIHEPATITIS; PERIODIC MEDICAL EXAMINATION; PHYSICAL EXAMINATION; REVIEW; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SINGLE DRUG DOSE; SYMPTOMATOLOGY; TUBOOVARIAN ABSCESS; UTERINE CERVIX MUCUS;

ADOLESCENT; ANTI-INFECTIVE AGENTS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; PELVIC INFLAMMATORY DISEASE; RISK FACTORS;

EID: 3142636633     PISSN: 15473368     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.admecli.2004.02.005     Document Type: Review

References (51)

1. Centers for Disease Control and Prevention. Sexually Transmitted Disease Surveillance, 2002. Atlanta (GA): US Department of Health and Human Services; 2003.
2. Jossens MR, Schachter J, Sweet RL. Risk factors associated with pelvic inflammatory disease of differing microbial etiologies. Obstet Gynecol 1994;83:989-97.
3. Ness RB, Soper DE, Holley RL, et al. Douching and endometritis: Results from PID evaluation and clinical health (PEACH) study. Sex Transm Dis 2001;28:240-5.
4. Zhang J, Thomas G, Leybovich E. Vaginal douching and adverse health effects: a meta-analysis. Am J Public Health 1997;87:1207-11.
5. Cates W, Rolfs RT, Aral SO. Sexually transmitted diseases, pelvic inflammatory disease, and infertility. An epidemiologic update. Epidemiologic Rev 1990;12:199-220.
6. Rice PA, Schachter J. Pathogenesis of pelvic inflammatory disease: What are the questions? JAMA 1991;266:2587-93.
7. Sweet RI, Blankfortdoyle MR. The occurrence of chlamydial and gonococcal salpingitis during the menstrual cycle. JAMA 1986;255:2062-4.
8. Shrier LA, Bowman FP, Lin M, Crowley-Nowick PA. Mucosal immunity of the adolescent female genital tract. J Adolesc Health 2003;32:183-6.
9. Chacko MR, Lovchik JC. Chlamydia trachomatis infection in adolescents: prevalence and risk factors. Pediatrics 1984;73:836-40.
10. Ness RB, Keder LM, Soper DE, et al. Oral contraception and recognition of endometritis. Am J Obstet Gynecol 1997;176:580-5.
11. Wolner-Hanssen P, Eshenbach OA, Paavonen J. Decreased symptomatic chlamydial pelvic inflammatory disease associated with oral contraceptive use. JAMA 1990;263:54-9.
12. Lee NC, Rubin GL, Boruck LR. The intrauterine device and pelvic inflammatory disease revisited: new results from the women's health study. Obstet Gynecol 1988;72:1-6.
13. Kessel E. Pelvic inflammatory disease with intrauterine device use: a reassessment. Fertil Steril 1989;51:1-11.
14. Hillis SD, Joesoef R, Marchbanks PA, Wasserheit JN, Cates W, Westrom L. Delayed care of pelvic inflammatory disease as a risk factor for impaired fertility. Am J Obstet Gynecol 1993;168:1503-9.
15. Spence MR, Adler J, McLellan R. Pelvic inflammatory disease in the adolescent. J Adolesc Health Care 1990;11:304-9.
16. Soper DE, Brockwell NJ, Dalton HP, Johnson D. Observations concerning the microbial etiology of acute salpingitis. Am J Obstet Gynecol 1994;170:1008-14.
17. Sweet RL, Draper DL, Schachter J, et al. Microbiology and pathogenesis of acute salpingitis as determined by laparoscopy: what is the appropriate site to sample? Am J Obstet Gynecol 1980;138:985-9.
18. Cohen CR, Manhart LE, Bukusi EA, et al. Association between Mycoplasma genitalium and acute endometritis. Lancet 2002;359:765-6.
19. Paavonen J, Teisala K, Heinonen PK. Microbiological and histopathological findings in acute pelvic inflammatory disease. Br J Obstet Gynaecol 1987;94:454-60.
20. Peipert JF, Montagno AB, Cooper AS, Sung CJ. Bacterial vaginosis as a risk factor for upper genital tract infection. Am J Obstet Gynecol 1997;177:1184-7.
21. Emans SJH. Sexually transmitted diseases: gonorrhea, Chlamydia trachomatis, pelvic inflammatory disease, and syphilis. In: Emans SJH, Laufer MR, Goldstein DP, editors. Pediatric and adolescent gynecology. 4th edition. Philadelphia, New York: Lippincott-Raven Publishers; 1998. p. 457-504.
22. Westrom L, Eschenbach D. Pelvic inflammatory disease. In: Holmes KK, Sparling PF, Mardh P, et al, editors. Sexually transmitted diseases. 3rd edition. Colorado Springs (CO): McGraw-Hill Health Professions Division; 1999. p. 783-9.
23. Wiesenfield HC, Hillier SL, Krohn MA, et al. Lower genital tract infection and endometritis: insight into subclinical pelvic inflammatory disease. Obstet Gynecol 2002;100:456-63.
24. Sweet RL, Draper DL, Hadley WK. Etiology of acute salpingitis: influence of episode number and duration of symptoms. Obstet Gynecol 1981;58:62-8.
25. Pavletic AJ, Wolner-Hanssen P, Paavonen J, Hawes SE, Eschenbach DA. Infertility following pelvic inflammatory disease. Infect Dis Obstet Gynecol 1999;7:145-52.
26. Golden N, Neuhoff S, Cohen H. Pelvic inflammatory disease in adolescents. J Pediatr 1989;114:138-43.
27. Bukusi EA, Cohen CR, Stevens CE, Sinei S, Reilly M, Greico V, et al. Effects of human immune deficiency virus 1 infection in microbial origins of pelvic inflammatory disease and on efficacy of ambulatory oral therapy. Am J Obstet Gynecol 1999;1819:1374-81.
28. Centers for Disease Control and Prevention. Sexually Transmitted Disease Treatment Guidelines 2002. MMWR Recomm Rep 2002;51(RR-6):48-52.
29. Peipert JF, Ness RB, Blume J, et al. Clinical predictors of endometritis in women with symptoms and signs of pelvic inflammatory disease. Am J Obstet Gynecol 2001;184:856-63.
30. Golden N, Cohen H, Gennari G, Neuhoff S. The use of pelvic ultrasonography in the evaluation of adolescents with pelvic inflammatory disease. Am J Dis Child 1987;141:1235-8.
31. Hager WD. Follow-up of patients with tubo-ovarian abscess(es) in association with salpingitis. Obstet Gynecol 1983;61:680-4.
32. Bulas DI, Ahlstrom PA, Sivit CJ. Pelvic inflammatory disease in the adolescent: comparison of transabdominal and transvaginal sonographic evaluation. Radiology 1992;183:435-9.
33. Ness RB, Soper DE, Holley RL, Peipert J, Randall H, Sweet RL. Effectiveness of inpatient and outpatient treatment strategies for women with pelvic inflammatory disease: results from the pelvic inflammatory disease evaluation and clinical health randomized trial. Am J Obstet Gynecol 2002;186:929-37.
34. Landers DV, Sweet RL. Current trends in the diagnosis and treatment of tubo-ovarian abscess. Am J Obstet Gynecol 1985;151:1098-110.
35. Safrin S, Schachter J, Dahrouge D, Sweet RL. Long term sequelae of acute pelvic inflammatory disease. A retrospective cohort study. Am J Obstet Gynecol 1992;166:1300-5.
36. Westrom L. Effect of acute pelvic inflammatory disease on fertility. Am J Obstet Gynecol 1975;121:707-13.
37. Svensson L, Mardh PA, Westrom L. Infertility after acute saplingitis with a special reference to Chlamydia trachomatis. Fertil Steril 1983;40:322-9.
38. Westrom L. Influence of sexually transmitted diseases on sterility and ectopic pregnancy. Acta Eur Fertil 1985;16:21-4.
39. Washington AE, Sweet RL, Shafer MB. Pelvic inflammatory disease and its sequelae in adolescence. J Adolesc Health Care 1985;6:298-310.
40. Wang SP, Eschenbach DA, Holmes KK, et al. Chlamydia trachomatis infection in Fitz-Hugh-Curtis syndrome. Am J Obstet Gynecol 1980;138:1034-8.
41. Lopez-Zeno JA, Berger LG. The Fitz-Hugh-Curtis syndrome revisited: changing perspectives after half a century. J Reprod Med 1985;30:567-82.
42. Livengood III CH. Tuboovarian abscess. Available at: http://www. 2003UpToDateOnline11.2. Accessed September 2003.
43. Tukeva TA, Aronen HJ, Karjalainen PT, Molander P, Paavonen T, Paavonen J. MR imaging in pelvic inflammatory disease: comparison with laparoscopy and US. Radiology 1999;210:209-15.
44. Mitchell DG, Minz M, Spritzer C, et al. Adnexal masses: MR imaging observations at 1.5 T with US and CT correlation. Radiology 1987;162:319-24.
45. Yamashita Y, Torashima M, Hatanaka Y. Adnexal masses: accuracy of characterization with transvaginal US and precontrast and postcontrast MR imaging. Radiology 1995;194:557-65.
46. McNeeley SG, Hendrix SL, Mazzoni MM, Kmack DC, Ransom SB. Medically sound, costeffective treatment for pelvic inflammatory disease and tubo-ovarian abscess. Am J Obstet Gynecol 1998;178:1272-7.
47. Walker CK, Landers DV. Pelvic abscesses: new trends in management. Obstet Gynecol Surv 1991;46:615-24.
48. Casola G, van Sonnenberg E, D'Agostino HB, et al. Percutaneous drainage of tubo-ovarian abscesses and fluid collections. Radiology 1991;182:399-402.
49. Van Sonnenberg E, D'Agostina HB, Casola G, Halasz NA, Sanchez RB, Goodacre BW. US-guided transvaginal drainage of pelvic abscesses and fluid collections. Radiology 1991;181:53-6.
50. Yeh JM, Hook III EW, Goldie SJ. A refined estimate of the lifetime cost of pelvic inflammatory disease. Sex Transm Dis 2003;30:369-78.
51. Centers for Disease Control and Prevention. Recommendations for the prevention and management of Chlamydia trachomatis infections, 1993. MMWR Recomm Rep 1993;42(RR-12):1 -37.